Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bernstein

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Medicine|November 1, 1992
The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-SclC Marguerie, C C Bunn, J Copier, et al.
British Journal of Rheumatology|April 1, 1993
Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosusL S Teh, E M Hay, N Amos, et al.
Rheumatology (Oxford, England)|March 27, 2007
Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotypeY Ahmad, J Shelmerdine, H Bodill, et al.
Arthritis and Rheumatism|March 1, 1993
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European CommunityC Vitali, S Bombardieri, H M Moutsopoulos, et al.
British Journal of Rheumatology|October 1, 1993
HLA-DQ, DR and complement C4 variants in systemic lupus erythematosusE J Davies, M C Hillarby, R G Cooper, et al.
British Medical Journal (Clinical Research Ed.)|March 27, 1982
Hydralazine, antinuclear antibodies, and the lupus syndromeR Mansilla-Tinoco, S J Harland, P J Ryan, et al.
European Journal of Rheumatology and Inflammation|January 1, 1992
Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulationsE C Huskisson, R M Bernstein, J S Coppock, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHCM C Panelli, E Wang, S Shen, et al.
Pediatrics|November 1, 1988
Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trialsJ W Kendig, R H Notter, C Cox, et al.
Clinical and Experimental Immunology|August 1, 1991
An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren's syndromeR A Kay, E M Hay, P A Dyer, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Medicine|November 1, 1992
The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-SclC Marguerie, C C Bunn, J Copier, et al.
British Journal of Rheumatology|April 1, 1993
Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosusL S Teh, E M Hay, N Amos, et al.
Rheumatology (Oxford, England)|March 27, 2007
Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotypeY Ahmad, J Shelmerdine, H Bodill, et al.
Arthritis and Rheumatism|March 1, 1993
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European CommunityC Vitali, S Bombardieri, H M Moutsopoulos, et al.
British Journal of Rheumatology|October 1, 1993
HLA-DQ, DR and complement C4 variants in systemic lupus erythematosusE J Davies, M C Hillarby, R G Cooper, et al.
British Medical Journal (Clinical Research Ed.)|March 27, 1982
Hydralazine, antinuclear antibodies, and the lupus syndromeR Mansilla-Tinoco, S J Harland, P J Ryan, et al.
European Journal of Rheumatology and Inflammation|January 1, 1992
Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulationsE C Huskisson, R M Bernstein, J S Coppock, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHCM C Panelli, E Wang, S Shen, et al.
Pediatrics|November 1, 1988
Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trialsJ W Kendig, R H Notter, C Cox, et al.
Clinical and Experimental Immunology|August 1, 1991
An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren's syndromeR A Kay, E M Hay, P A Dyer, et al.
Pageof 15